| Expression and amplification of HER-2/neu oncogene in uterine carcinosarcomas: a marker for potential molecularly targeted treatment?. | sarcoma,uterine, |
| HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells. | breast, |
| [Application of chromogenic in-situ hybridization in detecting HER-2/neu oncogene expression in breast carcinoma and its significance]. | breast, |
| Developmental and thyroidal regulation of the nuclear T3 receptors/c-erb A oncogene products in the Ob 17 preadipocyte cell line. | thyroid, |
| p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. | breast, |
| Subset of pancreatic ductal adenocarcinomas is characterized by HER2/neu gene amplification. (Her 2 protooncogene protein) | pancreatic, |
| c-erbB-2 oncogene as a prognostic marker in breast cancer. | breast, |
| c-erbB-2 oncoprotein expression in primary and advanced breast cancer. | breast, |
| Long-term survival in breast cancer related to overexpression of the c-erbB-2 oncoprotein: an immunohistochemical study using monoclonal antibody NCL-CB11. | breast, |
| Steroid receptor expression and HER-2/neu (c-erbB-2) oncoprotein in the uterus of cats with cystic endometrial hyperplasia-pyometra complex. | endometrial, |
| Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. | gastric, |
| A soluble protein related to the HER-2 proto-oncogene product is released from human breast carcinoma cells. | breast, |
| Expression of Her-2/neu oncogene protein product and epidermal growth factor receptors in surgical specimens of human breast cancers. | breast, |
| [Prognostic significance of expression of c-ERBB-2 oncoprotein in breast cancer patients]. | breast, |
| C-erbB-2 oncogene protein in in situ and invasive lobular breast neoplasia. | breast, |
| c-erbB-2 proto-oncogene expression and its relationship to survival in gastric carcinoma: an immunohistochemical study on archival material. | gastric, |
| Quantitation of HER-2/neu oncoprotein overexpression in invasive breast cancer by image analysis: a study comparing fresh and paraffin-embedded material. | breast, |
| Prognostic significance of immunohistochemical expression of the HER-2/neu oncoprotein in bone metastatic prostate cancer. | prostate, |
| Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer: retrospective follow-up study of 245 stage I and II cases. | breast, |
| Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-methyl-N-nitrosourea. | bladder, |